Sandoz, a subsidiary of Swiss pharmaceutical giant Novartis, has agreed to pay $195 million to avoid trial on charges it conspired to fix prices of generic drugs, US prosecutors announced Monday.
Read More
Sandoz, a subsidiary of Swiss pharmaceutical giant Novartis, has agreed to pay $195 million to avoid trial on charges it conspired to fix prices of generic drugs, US prosecutors announced Monday.
Read More
Health Rss 